Feedback / Questions
trabedersen (OT-101) - Autotelic, Oncotelic
Keytruda (pembrolizumab) - Merck (MSD)
https://www.globenewswire.com/news-release/2021/12/01/2344232/0/en/Oncotelic-Initiates-Phase-2-Trial-Evaluating-OT-101-in-Combination-with-KEYTRUDA-for-Mesothelioma.html
Dec 1, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next